Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proparacaine for Canalicular Probing Comfort
NCT04229771Phase 4Terminated
- Sponsor
- Corewell Health
- Start
- Jun 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of proparacaine in epiphora (2 arms), sponsored by Corewell Health. Primary endpoint: Count of Participants Who Report of Less Discomfort in the Eye That Received the Proparacaine Hydrochloride Anesthetic During Probing at 1 minute. Started Jun 2020; status: terminated.
02
Drugs
proparacaine
03
Conditions
epiphora
Beyond the preview
Go deeper on NCT04229771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04229771.